Therapies Compared for Newly Diagnosed Multiple Sclerosis

THURSDAY, Sept. 10, 2026-- For patients with newly diagnosed multiple sclerosis (MS), B-cell-depleting therapies (BCDTs) and high-efficacy therapies have greater effects on acute inflammatory outcomes than progression-related outcomes, according...